Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Outlook TherapeuticsBioCardiaEntera BioTitan PharmaceuticalsGenetic Technologies
SymbolNASDAQ:OTLKOTCMKTS:BCDANASDAQ:ENTXNASDAQ:TTNPNASDAQ:GENE
Price Information
Current Price$0.62$2.76$2.37$0.25$1.87
52 Week RangeBuyBuyBuyBuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$9.00$18.33$8.00$1.00N/A
% Upside from Price Target1,351.61% upside564.25% upside238.05% upside300.00% upsideN/A
Trade Information
Market Cap$18.42 million$18.84 million$27.04 million$17.01 million$9.30 million
Beta-0.631.971.720.83.24
Average Volume438,47923,4836,26522,235,87646,935
Sales & Book Value
Annual Revenue$8.15 million$630,000.00$240,000.00$6.62 million$20,000.00
Price / Sales2.2929.90112.702.51457.93
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.56) per share$0.78 per share$0.89 per share$0.53 per share$0.26 per share
Price / Book-1.113.542.660.477.19
Profitability
Net Income$-34,520,000.00$-13,990,000.00$-10,300,000.00$-9,020,000.00$-4,600,000.00
EPS($1.98)N/AN/A($0.79)N/A
Trailing P/E RatioN/A0.00N/AN/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-423.83%-2,191.28%N/A-441.23%N/A
Return on Equity (ROE)N/A-423.10%-178.25%-962.95%N/A
Return on Assets (ROA)-153.16%-227.05%-116.58%-170.44%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A1.24%0.04%N/A0.05%
Current Ratio0.33%1.06%2.65%1.13%2.95%
Quick Ratio0.33%1.03%2.65%0.76%2.90%
Ownership Information
Institutional Ownership Percentage4.85%1.01%16.83%2.89%2.72%
Insider Ownership Percentage4.00%26.00%N/A1.40%N/A
Miscellaneous
Employees56271923N/A
Shares Outstanding30.10 million6.83 million11.43 million66.58 million4.90 million
Next Earnings Date5/20/2020 (Estimated)N/A6/25/2020 (Estimated)3/30/2020 (Confirmed)N/A
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel